文献速递心力衰竭与心肌病

优化老年心力衰竭患者的治疗策略:美国心脏协会科学声明

Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association.
PubMed 文献 · Circulation · 2026-06-18

该科学声明围绕 65 岁及以上老年心力衰竭患者,综述了优化诊疗的相关文献与策略。声明指出老年患者面临指南导向治疗可及性与实施障碍,需制定个体化方案。重点阐述指南导向治疗的一致疗效与安全性,以及通过共同决策管理多病共存、多重用药、衰弱和社会需求。

要点

  • 老年心衰患者使用指南导向治疗仍有一致疗效与安全性,不应仅因年龄而限制使用。
  • 需结合获益风险比、多病共存与社会需求,采用共同决策框架制定个体化方案。
  • 照护复杂老年心衰患者时,还应关注多重用药、衰弱及健康服务干预与支持工具。

核心结论

  • 老年心力衰竭患者需要个体化治疗计划,以克服有效治疗的实施障碍并改善结局。
  • 临床医生和卫生系统应采用结构化框架,在获益风险比、多病共存和社会需求背景下优化老年心衰照护。

研究设计与样本

  • 该文为美国心脏协会科学声明,综述 65 岁及以上老年心力衰竭患者的诊疗优化文献,并提出临床策略。
  • 声明讨论了在常见老年共病背景下提供以患者为中心、循证心衰照护的方法,以及实施策略和健康服务干预。

主要发现

  • 指南导向心力衰竭治疗在老年患者中具有一致的治疗效果与安全性。
  • 老年患者可能面临获取和接受全面疾病修饰、指南导向治疗的特殊挑战,限制了在高危人群中的使用。
  • 共同决策框架可用于管理老年心衰患者的多病共存、多重用药、衰弱和社会需求。
  • 部分合并晚期共病的老年患者在里程碑式临床试验中代表性不足,声明提供了相关实用指导。

关键数值与推荐

  • 声明强调在获益风险比、多病共存和社会需求背景下考虑治疗的结构化框架。
  • 老年心力衰竭照护需纳入多重用药、衰弱、社会需求及共同决策等关键要素。
  • 声明为合并晚期共病、可能未充分纳入关键试验的老年患者提供实用照护建议。

临床怎么用

  • 临床医生应采用共同决策框架,结合老年患者的共病、衰弱、多重用药和社会需求制定心衰治疗方案。
  • 卫生系统可通过实施策略、健康服务干预和支持工具促进老年心衰患者获得最佳照护。
  • 对于合并晚期共病的老年患者,应依据个体化获益风险评估给予指南导向治疗,而非仅因年龄排除。

局限性

  • 部分合并晚期共病的老年患者在关键试验中代表性可能不足,相关推荐需谨慎外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure prevalence is increasing and has a disproportionate burden on older adults. Older adults, however, may encounter unique challenges in accessing and navigating comprehensive disease-modifying, guideline-directed therapies, thus limiting use among those at highest risk of cardiovascular death or worsening heart failure. Care of the older adult with heart failure requires tailored treatment plans to overcome barriers to effective therapies in this population. This scientific statement reviews the literature on care optimization for older adults (≥65 years of age) living with heart failure and highlights strategies for clinicians who aim to deliver patient-centered, evidenced-based heart failure care in the context of common comorbidities seen in older adults. We discuss the consistent treatment effect and safety profiles of guideline-directed therapies for heart failure in older adults and how to manage multimorbidity, polypharmacy, frailty, and social needs using a shared decision-making framework. In consideration of the complexity of heart failure care of the older adult, we highlight a structured framework for therapeutic considerations in the context of benefit-to-risk ratio, multimorbidity, and social needs. We offer practical guidance on the care of older adults with advanced comorbidities who may not have been adequately represented in landmark trials. We also consider implementation strategies, health services interventions, and supportive tools that may foster optimal care in older adults with heart failure. This work is aimed at informing the practice of clinicians and health systems alike to improve outcomes and to reduce the morbidity of heart failure in older adults.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Lewsey, Martyn, Blumer, et al. Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association. Circulation. 2026. PMID: 42312386. doi:10.1161/CIR.0000000000001437

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。